PAVmed Inc.
PAVM
$0.5757
$0.00971.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.99M | 3.00M | 4.03M | 3.83M | 3.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.99M | 3.00M | 4.03M | 3.83M | 3.02M |
| Cost of Revenue | 3.13M | 4.84M | 6.40M | 6.80M | 6.82M |
| Gross Profit | -1.14M | -1.84M | -2.37M | -2.97M | -3.80M |
| SG&A Expenses | 29.79M | 36.15M | 43.53M | 44.84M | 44.58M |
| Depreciation & Amortization | 187.00K | 559.00K | 1.06M | 1.49M | 1.89M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.89M | 47.48M | 59.72M | 63.46M | 65.45M |
| Operating Income | -35.90M | -44.49M | -55.68M | -59.63M | -62.43M |
| Income Before Tax | 65.56M | 28.43M | 9.88M | -72.58M | -75.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 65.56 | 28.43 | 9.88 | -72.58 | -75.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.41M | 11.36M | 14.45M | 14.84M | 14.11M |
| Net Income | 73.97M | 39.79M | 24.32M | -57.75M | -61.46M |
| EBIT | -35.90M | -44.49M | -55.68M | -59.63M | -62.43M |
| EBITDA | -35.24M | -43.29M | -53.83M | -57.28M | -59.64M |
| EPS Basic | 6.64 | 2.74 | 0.63 | -8.17 | -9.08 |
| Normalized Basic EPS | -0.92 | -1.47 | -2.74 | -3.19 | -3.74 |
| EPS Diluted | 0.58 | -2.38 | -4.35 | -8.18 | -9.08 |
| Normalized Diluted EPS | -0.58 | -1.18 | -2.50 | -3.19 | -3.74 |
| Average Basic Shares Outstanding | 43.86M | 38.68M | 35.88M | 33.33M | 31.14M |
| Average Diluted Shares Outstanding | 238.08M | 194.28M | 70.35M | 33.33M | 31.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |